Using imaging for cardiovascular risk prediction: an overview.
Atherosclerosis is a systemic, silent, and deadly disease; however, primary risk reduction is very effective. Cost-effective risk modification relies on accurate and individualized risk stratification; however, traditional risk factor-based assessments fail to account for individual progression along the pathophysiologic continuum. Ultrasound and other imaging techniques that measure both anatomy and function provide well-validated surrogate markers for atherosclerosis that have incremental predictive power to that provided by risk factors, and may be useful in designing primary prevention strategies.
Douglas
Pamela S
PS
Department of Medicine, University of Wisconsin Medical School, Madison, 53792, USA. psd@medicine.wisc.edu
D001161:Arteriosclerosis / Q000000981:diagnostic imaging*; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D005544:Forecasting; D006801:Humans; D011237:Predictive Value of Tests; D018570:Risk Assessment; D014463:Ultrasonography